John A. Stalfort III

Director at Taysha Gene Therapies · 3 reported transactions in 2 companies · latest report Jun 1, 2026

Their trades


Taysha Gene TherapiesTSHA	Share award — · 21,335 shares	Jun 1, 2026
Acumen PharmaceuticalsABOS	Share award — · 12,800 shares	Jun 4, 2025
Taysha Gene TherapiesTSHA	Share award — · 56,623 shares	Jun 2, 2025

Jun 1, 2026 · TSHA

21,335

Jun 4, 2025 · ABOS

12,800

Jun 2, 2025 · TSHA

56,623

3 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.